Abstract
The role of gut microbiome-intestinal immune complex in the development of colorectal cancer and its progression is well recognized. Accordingly, certain microbial strains tend to colonize or vanish in patients with colorectal cancer. Probiotics, prebiotics, and synbiotics are expected to exhibit both anti-tumor effects and chemopreventive effects during cancer treatment through mechanisms such as xenometabolism, immune interactions, and altered eco-community. Microbial modulation can also be safely used to prevent complications during peri-operational periods of colorectal surgery. A deeper understanding of the role of intestinal microbiota as a target for colorectal cancer treatment will lead the way to a better prognosis for colorectal cancer patients.
| Original language | English |
|---|---|
| Pages (from-to) | 31-42 |
| Number of pages | 12 |
| Journal | Intestinal Research |
| Volume | 20 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 13 Climate Action
Keywords
- Colon neoplasms
- Intestinal microbiome
- Prebiotics
- Probiotics
- Synbiotics
Fingerprint
Dive into the research topics of 'The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver